Abstract The aging kidney undergoes structural and functional alterations which make it more susceptible to drug-induced acute kidney injury (AKI). Previous studies in our lab have shown that the expression of a(E)-catenin is decreased in aged kidney and loss of a(E)-catenin potentiates AKI-induced apoptosis, but not necrosis, in renal tubular epithelial cells (NRK-52E cells). However, the specific apoptotic pathway underlying the increased AKIinduced cell death is not yet understood. In this study, cells were challenged with nephrotoxicant cisplatin to induce AKI. A *5.5-fold increase in Fas expression in C2 (stable a(E)-catenin knockdown) relative to NT3 (non-targeted control) cells was seen. Increased caspase-8 and -9 activation was induced by cisplatin in C2 as compared to NT3 cells. In addition, decreased Bcl-2 expression and increased BID cleavage and cytochrome C release were detected in C2 cells after cisplatin challenge. Treating the cells with cisplatin, in combination with a Bcl-2 inhibitor, decreased the viability of NT3 cells to the same level as C2 cells after cisplatin. Furthermore, caspase-3/-7 activation is blocked by Fas, caspase-8, caspase-9 and pan-caspase inhibitors. These inhibitors also completely abolished the difference in viability between NT3 and C2 cells in response to cisplatin. These results demonstrate a Fas-mediated apoptotic signaling pathway that is enhanced by the age-dependent loss of a(E)-catenin in renal tubule epithelial cells.
Introduction
Aging is a major challenge facing scientists and doctors today because of the substantial increase in the human lifespan during the last century [1] . By 2050, it is expected that the number of individuals aged 60 or more will double, accounting for 11 %, currently, to 22 % of world's population [2] . Several structural and functional alterations occur in the aging kidney which makes aging a major risk factor for acute kidney injury (AKI) [3] . Clinical studies performed in Spain showed the incidence of AKI is 3.5 times higher in aged patients (C70 years) compared with those less than 70 years old [4] . In addition, increased medication use in elderly patients can also increase the incidence of AKI since nephrotoxic drugs are the cause for approximately 20 % of AKI cases [5] . In our study, cisplatin, a widely used nephrotoxicant-induced AKI model, was used to investigate the pathophysiological mechanism of AKI in aged kidney [6] .
a-Catenin, which bridges the E-cadherin-b catenin complex and actin cytoskeleton, is essential for maintaining the integrity of the intercellular adherens junction [7] . There are three forms of a-catenin: neural (N), epithelial (E) and testis/heart (T) [8] . There is an increasing recognition that in addition to the well-established role in cell adhesion, a-catenin regulates multiple pathways controlling cell density, polarity, proliferation and apoptosis [9] [10] [11] . Previous studies in our lab have shown the expression of a(E)-catenin is dramatically decreased in proximal tubular epithelium cells in aged male Fisher 344 rats [12] . The decreased expression of a(E)-catenin is coupled with increased cisplatin induced apoptosis, rather than necrosis, in a caspase dependent manner [13] .
The intrinsic and extrinsic pathways are two major caspase-dependent pathways to induce apoptosis, which are distinguished by the initiating signal [5] . The intrinsic pathway is triggered by cell stress-induced mitochondria outer membrane permeabilization (MOMP), resulting in the release of cytochrome c that activates caspase-9. The extrinsic pathway is initiated by the binding of apoptotic ligand to death receptors leading to the activation of caspase-8. Both intrinsic and extrinsic pathways will ultimately cleave caspase-3/-7 which initiates the morphological changes of apoptosis [14] . In this study, the specific apoptotic pathway promoted by decreased a(E)-catenin was identified by using a stable a(E)-catenin knockdown cell line (C2 cells) generated in NRK-52E cells; NT3 cells will be used as the non-targeted control [15, 16] . These results provide the initial evidence that age-dependent loss of a(E)-catenin increases the susceptibility to acute kidney injury by facilitating the Fas-mediated apoptosis pathway in renal tubule epithelial cells.
Results
Target genes involved in apoptosis were assessed by RT 2 Profiler PCR Array in NT3 and C2 cells. The gene expression (fold-change) in C2 cells relative to NT3 cells is depicted by the heat map with up-regulation in red and down-regulation in green (Fig. 1) . The up-regulated genes include Fas, TNF-a related genes, caspases and pro-apoptotic Bcl-2 family members. The down-regulated genes include Card 10, II10 and Birc3, which are mainly antiapoptotic [17] .
Fas and TNF-a are two major death receptors that mediate the extrinsic apoptosis pathway [14] . Real-time PCR revealed the Fas mRNA was elevated 5.5-fold in C2 Cells relative to NT3 cells (Fig. 2a) , which is consistent with the PCR Array result (Fig. 1 ). In addition, increased protein expression of Fas ligand (FasL) was detected in C2 cells but not NT3 cells after cisplatin treatment (Fig. 2b, c) . The protein expression of Fas was constantly higher in C2 cells than in NT3 cells before and after cisplatin treatment (Fig. 2b, d ). Confluent cultures of NT3 and C2 cells were challenged with cisplatin in combination with Kp7-6 (FasL/Fas antagonist) for 24 h. C2 cells exhibited a significant loss of viability after cisplatin injury as compared with NT3 cells and the susceptibility difference between NT3 and C2 cells to cisplatin was completely abolished by Kp7-6 (Fig. 2f) . Although C2 cells showed higher mRNA expression of TNF-a (Fig. 3a) , no difference in TNF-a protein expression was observed between NT3 and C2 cells (Fig. 3b, c) . Furthermore, pentoxifylline, a TNF-a inhibitor, failed to rescue C2 cells from the decreased viability as compared with NT3 cells in response to cisplatin (Fig. 3d, e) . Taken together, these results indicate Fas, rather than TNF-a, mediates the increased cisplatin-induced apoptosis in C2 cells.
Caspase-8, a member of the cysteine proteases, is directly recruited by the Fas-associated death domain (FADD) [18] . A Caspase-Glo 8 Assay was performed to assess the activity of caspase-8. No significant difference was detected in the basal caspase-8 activity between NT3 and C2 cells. However, C2 cells had increased caspase-8 activation than NT3 cells after cisplatin treatment in a time-dependent manner (Fig. 4a) . Interestingly, similar results were observed in a Caspase-Glo 9 Assay (Fig. 4b) . Treating the cells with Z-IETD-FMK (caspase-8 inhibitor), Z-LEHD-FMK (caspase-9 inhibitor) and Z-VAD (pancaspase inhibitor) abolished the difference between NT3 and C2 cells to cisplatin (Fig. 4c) . Since caspase-9 is an initiator caspase, which plays a critical role in intrinsic apoptosis pathway [19] , these data suggested the involvement of mitochondria in the pathway. Members of the Bcl-2 family govern MOMP and have either anti-apoptotic (Bcl-2) or pro-apoptotic (BID) function [20] . Western blot was performed to measure the protein expression of Bcl-2 members (Fig. 5a ). Increased BID cleavage was induced by cisplatin in C2 relative to NT3 cells (Fig. 5c) . Correspondingly, lower Bcl-2 expression was observed in basal C2 cells. After cisplatin treatment, the expression of Bcl-2 was further decreased in C2 cells, but not in NT3 cells (Fig. 5d ). This result was consistent with in vivo data. Aged kidneys have increased BID cleavage (Fig. 5e , f) and decreased Bcl-2 expression ( Fig. 5e-g ) compared to young kidney. Cisplatin induced a further increase of BID cleavage and decrease of Bcl-2 expression in aged kidney. However, the BID cleavage and Bcl-2 expression in young kidney were not influenced by cisplatin. Cytosolic cytochrome c was also measured (Fig. 5a ), which revealed that cisplatin induced more cytochrome c release in C2 than NT3 cells (Fig. 5b) . Importantly, ABT-199, a Bcl-2 inhibitor, decreased the viability of NT3 cells in a dose-dependent manner and completely abolished the viability difference between NT3 and C2 cells at the dose of 10 nM (Fig. 5h ). These results demonstrate a key role for the mitochondria in the apoptosis pathway and the decreased viability of C2 cells to cisplatin may be due to decreased anti-apoptotic Bcl-2 expression.
Caspase-3 and caspase-7 are effector caspases that can be activated by either the extrinsic (caspase-8) or intrinsic (caspase-9) pathway leading to apoptosis [21] . Previous studies in our lab showed increased caspase-3/-7 activation in C2 cells after cisplatin treatment [13] . A Caspase-Glo 3/-7 Assay was used to measure the activity of caspase-3/-7 ( Fig. 6 ). Z-IETD-FMK, Z-LEHD-FMK and Z-VAD completely blocked caspase-3/-7 activation induced by cisplatin in NT3 and C2 cells, which indicates that caspase-3/-7 is downstream of both caspase-8 and -9 in the pathway. Interestingly, treating the cells with cisplatin in combination with Kp -6, a FasL/Fas antagonist, selectively decreased the cisplatin-induced caspase-3/-7 activation in C2 cells to the level of NT3 cells. These data demonstrate that loss of a(E)-catenin promotes apoptosis by increasing Fas signaling in renal tubule epithelial cells. 
Discussion
These results provide the first evidence that, in renal tubule epithelial cells, loss of a(E)-catenin increases the susceptibility to acute injury by enhancing a Fas mediated apoptosis pathway. a-Catenin, previously known as a linking protein between the cadherin-b-catenin complex and actin cytoskeleton, has recently been shown to exert other functions [22] . Our study focused on the role of a-catenin in regulating cell death since renal tubular epithelium cell death is a hallmark of AKI [23] . Increased apoptosis has been reported in a-catenin deleted mammary glands of mice [24] . In addition, increased expression of p53 was coupled to decreased a-catenin expression in both gastric and lung cancer [25] . However, in epidermis or central nervous systems, deletion of a-catenin has been reported to have a protective effect from apoptosis by up regulating NF-jB [26] . a-Catenin knockdown in epithelial cancer cells also attenuates DR4/DR5 mediated apoptosis [27] . In a myeloid leukemia cell line, reintroducing a-catenin leads to a decrease in cell proliferation and increase in apoptosis [28] . Hence, the role of a-catenin in cell death may depend on the cellular context. Our laboratory generated a stable a- N = 3) . The asterisks indicate significant differences between NT3 and C2 cells previous study showed C2 cells are more susceptible to staurosporine, a commonly used drug to induce apoptosis, but not inorganic mercury which induces necrosis in renal epithelial cells [13] . Increased susceptibility to cisplatin was also detected in C2 cells, and data suggests that the increased susceptibility is due to increased apoptosis rather than necrosis [13] .
Apoptosis, or programed cell death, is a fundamental process needed to maintain homeostasis [29] . Two major pathways have been demonstrated to induce apoptosis: the mitochondrial mediated intrinsic pathway and the receptordependent extrinsic pathway [30] . Treating the cells with cisplatin induced more caspase-8 and caspase-9 activation in C2 cells, which indicates both the intrinsic and extrinsic pathways are involved (Fig. 4a, b) . The crosstalk between the extrinsic and intrinsic pathways occurs through caspase-8 [6] . High levels of caspase-8 directly cleaves caspase-3/-7 leading to apoptosis, while low levels of caspase-8 cleaves BID to truncated BID (tBID), which translocates to the mitochondria membrane to activate the intrinsic pathway by inducing MOMP [31, 32] . Our studies showed that Z-LEHD-FMK, the caspase-9 inhibitor, is able to abolish the viability difference between NT3 and C2 similar to Z-IETD-FMK, the caspase-8 inhibitor (Fig. 4c) . This demonstrates that the cisplatin induced elevation of caspase-8 activity in C2 cells initiated the mitochondria mediated apoptosis pathway rather than leading to apoptosis directly. Concurrently, increased BID cleavage and cytochrome C release were detected in C2 cells after the cisplatin injury as compared to NT3 cells (Fig. 5a-c) . Importantly, the expression of Bcl-2, which is an apoptosis inhibitor, was decreased in C2 cells (Fig. 5d) . Meanwhile, increased BID cleavage and decreased Bcl-2 expression were also detected in aged rat kidney. The cisplatin challenge induced further increase of BID cleavage and decrease of Bcl-2 in C2 cells and aged kidney, but not in NT3 (Fig. 5h ). These results demonstrate that the increased susceptibility of C2 cells to cisplatin is due to the increased activity of the caspase-8/mitochondria/caspase-9 pathway, and the decreased expression of Bcl-2, which works as a suppressor in this apoptosis pathway. Apoptosis can also be induced by endoplasmic reticulum (ER) stress [33] . However, this possibility was excluded because caspase-12 expression is not different between young and aged kidney (data not shown). The receptor Fas, also called CD95, is a member of TNF receptor superfamily [34] . When Fas encounters its ligand FasL, the receptor trimerizes in the cytoplasmic domain and recruits the Fas-associated death domain protein (FADD). The death effector domain on FADD is capable of recruiting, cleaving and activating caspase-8 [35] . FasL is most prevalent in natural killer (NK) cells and T lymphocytes [31] . In the kidney, FasL has been reported to be expressed in tubular epithelial cells, renal endothelial cells, renal fibroblasts and mesangial cells [36] . Evidence has shown that FasL plays a key role in mediating cisplatininduced AKI [37] . The expression of Fas is significantly reduced in cisplatin-resistant ovarian cancer epithelial cells, and up-regulation of Fas reverses the development of cisplatin resistance [38] . Epigallocatechin-3-gallate, a green tea polyphenol, and amifostine ameliorate cisplatin nephrotoxicity by inhibiting Fas-dependent apoptosis [39, 40] . FasL expression was increased dramatically in cisplatin exposed HeLa cells after centrocyte/centroblast marker 1 stimulation [41] . In our study, increased expression of Fas was detected in C2 cells (Fig. 1 ). Kp7-6, a Fas/ FasL antagonist, abolished the cisplatin induced viability difference between NT3 and C2 cells (Fig. 2e) . Most (tBID) translocates to the surface of the mitochondria inducing cytochrome c release into the cytosol. The cytosolic cytochrome c activates caspase-9, followed by the activation of downstream caspase-3/-7. Bcl-2 is a negative regulator which inhibits the release of cytochrome c from mitochondria importantly, caspase-3/-7 activity was decreased by Kp7-6 in C2 cells, but not in NT3 cells (Fig. 6 ). These data confirmed that increased Fas mediated apoptosis is the cause of increased susceptibility of C2 cells to acute injury. A possible scheme of the Fas apoptotic signaling pathway is shown in Fig. 7 .
In conclusion, this study showed that age dependent loss of a(E)-catenin in renal tubule epithelial cells facilitate the Fas mediated apoptotic signaling pathway in response to cisplatin-induced AKI injury. This result may explain, in part, the increased incidence of AKI in aged kidney and shed light on the development of prospective treatments to AKI in aged patients.
Materials and methods

Materials
The following chemicals were used in the experiments. 
Animals
Male Fisher 344 rats (4-, and 24-month-old) were obtained from the NIA colony. Animals were randomly assigned to the cisplatin treated group and saline control group with N = 5 each. Animals received a single intraperitoneal (IP) injection of 2.75 mg/kg cisplatin, or an equal volume of saline as control. Animals were placed in metabolic cages overnight before harvesting. 72 h after cisplatin injection, rats were anesthetized with ketamine (80-120 mg/kg)/xylazine (5-10 mg/kg) via IP injection. Kidney tissue lysates were obtained to perform western blot. All animal experiments and care were approved by the University of Missouri Animal Care and Use Committee in accordance with the National Institutes of Health (NIH).
Cell culture
C2 (single cell clone of stable a(E)-catenin knockdown) and NT3 (vector control) cells were generated and cultured as previously described [15, 16] ; and used within 20 passages of establishing the clonal cell line for all studies. For these experiments, cells were plated at a density of 5 9 10 4 cells/cm 2 and cultured in DMEM/F12 (1:1) with L-glutamine and HEPES (Gibco Cat #11039-021) supplemented with 10 % fetal bovine serum (FBS) (Atlanta Biologicals Cat #S11150), 5 lg/ml puromycin dihydrochloride (Sigma Cat #P9620) and incubated at 37°C in 5 % CO 2 . Cells were harvested with TrypLE TM Express (Gibco Cat #12604-021) and pelleted at 1500 rpm for 5 min. at room temperature (RT).
RT 2 Profiler PCR Array
Total RNA was extracted using the RNeasy mini kit (Qiagen Cat #74104) and subjected to cDNA synthesis using the RT 2 Easy First Strand Kits (Qiagen Cat # 330421). Genes associated with apoptosis were assessed by real time RT 2 Profiler Rat Apoptosis PCR Array (Qiagen Cat# PARN-012Z) following the kit protocol.
MTT assay
Cells were seeded in a 96 well flat bottom tissue culture plate (Sigma Cat #Z707910) at a density of 5 9 10 4 cells/ cm 2 . After 24 h, culture media was replaced by serum free (SF) media supplemented with desired treatments. Three hours before harvest, 10 ll of 5 mg/ml MTT (Sigma Cat #M2128), dissolved in DPBS (Gibco Cat #14190-144), was added to each well. Upon harvesting, cells were washed with cold DPBS and dissolved by adding 50 ll solubilization solution (10 % Triton X-100, 0.1 N HCl in isopropanol). The plates were read at 570/690 nm on the Synergy HT Multi-Detection Microplate Reader (BioTek, Winooski, VT). The results are expressed by percent viability as [Abs 570-690 treated/Abs 570-690 control 9 100].
Real-time PCR 1 9 10 7 cells were harvested and suspended in 1 ml PBS. RNA was isolated using the NucleoSpin (Clotech Cat #740955) followed by determining the RNA concentration using NanoDrop 2000c Spectrophotometer (Thermo Scientific, Waltham, MA). cDNA was generated from 2 lg RNA using the High Capacity cDNA Synthesis Kit (Life Technologies Cat #4368814). Quantitative PCR was performed in duplicate using 50 ng cDNA/reaction via Taqman assays with SsoFast TM Probes Supermix with ROX (Bio-Rad Cat #172-5251) and the CFX96 Touch TM Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA). The following cycling conditions were used: 95°C for 20 s, then 95°C for 1 s and 60°C for 20 s repeated 40 times. Commercially available TaqMan primer sets were used to assess Fas (Rn00685720_m1) (Life technologies Cat #4331182) and TNF-a (Rn01525859_g1) (Life technologies Cat #4453320). Relative quantitation was performed using the Pfaffl method [1] normalized to Casc3.
Caspase activity assay
Confluent cultures of NT3 and C2 cells in 96 well plates were challenged with desired treatments. Caspase activity was determined by Caspase-Glo Ò 3/7 Assay (Promega Cat #G8091), Caspase-Glo Ò 8 Assay (Promega Cat #G8201) and Caspase-Glo Ò 9 Assay (Promega Cat #G8211), according to the manufacturer's instructions.
Western blot
Subconfluent cells were washed twice with ice-cold DPBS and lysed with lysis buffer (10 mM Tris-HCl, 1 % SDS) containing Halt TM Protease/Phosphatase inhibitors (Thermo Scientific Cat #78444). Cells were scraped and incubated on a rocker for 15 min at 4°C. Cells were further disrupted by pipetting 15 times and spun at 12,0009g for 15 min at 4°C. Protein concentration was determined by NanoDrop 2000c Spectrophotometer at 280 nm.
The following antibodies were used: Cytochrome c Release Assay Kit (GeneTex Cat #GTX85531), TNF-a (NOVUS Cat #NB600-587), BID (NOVUS Cat #NB100-56106), Bcl-2 (Cell Signaling Cat #2876), Fas (Abcam Cat #15285), FasL (Abcam Cat #82419) and anti-b-actin (Sigma Cat #A2228). Goat-anti-mouse HRP conjugate and Goat-anti-rabbit HRP conjugate (Jackson ImmunoResearch Laboratories, Cat #115035003 and 305035003) were used at 1:20,000 dilutions. Blots were developed using SuperSignal West Femto Chemiluminescent Substrate (Pierce Cat #34095), imaged using the ChemiDoc TM imaging system (Bio-Rad, Hercules, CA, USA), and quantitation performed using the ImageLab 3.0 software (Bio-Rad, Hercules, CA, USA).
Statistics
Results are expressed as mean ± SE. A two-way analysis of variance (ANOVA) was performed with the exception of Figs. 2a, c, d and 3a in which a one-way ANOVA was performed, followed by Student's t test using the statistical software GraphPad Prism 6 (GraphPad Software, La Jolla, CA, USA). The differences were considered statistically significant when p \ 0.05.
